Cancer kills millions of individuals every year all over the world (Global Cancer
Observatory). The physiological and biomechanical processes underlying the tumor are still …

Simple Summary Prostate cancer continues to exert a significant public health burden
across the globe with hundreds of thousands of new diagnoses per year. There have been …

Abstract Purpose Prostate cancer (PCa) is one of the most common cancers and one of the
leading causes of death worldwide. Thus, one major issue in PCa research is to accurately …

Simple Summary Prostate cancer is a disease responsible for a large proportion of all male
cancer deaths but there is a high chance that a patient will die with the disease rather than …

The highly heterogeneous clinical course of human prostate cancer has prompted the
development of multiple RNA biomarkers and diagnostic tools to predict outcome for …

Prostate cancer is a highly heterogeneous disease and the second more common tumor in
males. Molecular and genetic profiles are currently used to identify subtypes and to guide …

Prostate cancer (PC) is a polygenic disease with multiple gene interactions. Therefore, a
detailed analysis of its epidemiology and evaluation of risk factors can help to identify more …

Clinical management of prostate cancer is challenging because of its highly variable natural
history and so there is a need for improved predictors of outcome in non-metastatic men at …

Cancer classification plays an important role in the clinical management of cancer patients. It
enables clinicians to predict how individual cancers will behave and directs the best course …

Although there have been many advances in screening programs and treatments in recent
years that have reduced the mortality rate of cancer, it remains the second leading cause of …